Patient lifestyle

Preserving Patient Freedom With PD

Our peritoneal dialysis (PD) products and services can help people with kidney disease to maintain their chosen lifestyle. We were the first to make this therapy broadly available to patients,1 and we continue to drive it forward with a range of dialysis solutions and our automated PD cycler with digital connectivity. Our Sharesource connectivity platform for PD allows clinicians to review treatment data and take timely action.

Improving access to PD therapy and raising the quality of care

Since pioneering peritoneal dialysis in 1960, we have been committed to providing patients with chronic kidney disease (CKD) with this lifesaving therapy. This treatment option enables patients undergoing peritoneal dialysis at home to maintain their lifestyle and independence while offering potentially better clinical outcomes and substantially lower costs — benefitting patients, providers and healthcare systems alike.2

Through its partnership with the nephrology community, Vantive is committed to improving access to PD therapy and raising the quality of care to help achieve better outcomes for patients. Today, we offer the market’s most comprehensive PD portfolio, including the first and most thoroughly studied renal RPM platform. We believe in the value PD brings and are focused on making it the preferred initial choice of dialysis therapy through smarter patient-first solutions.

Man reading a book while receiving treatment

Benefits of PD therapy

Life goals

PD patients are more satisfied with their treatment compared to haemodialysis (HD) patients3,4

Early survival

PD offers significant early survival benefits vs in-centre haemodialysis5

Preservation of residual kidney function

PD allows a better preservation of residual kidney function than HD for patients starting dialysis, and this is associated with better patient survival6,7

Bridge to transplant

PD is associated with favourable post-transplant outcomes8

Preservation of vascular access

Initiating dialysis with PD preserves vascular access and eliminates the risk of HD access infections and complications7

Reduced infections and hospitalisation rates

Evidence-based preventative strategies have significantly improved peritonitis rates over the past decade9,10

Broad patient candidacy

At least 78% of patients have no absolute medical or psychosocial contraindication for PD11

Multiple therapy options

The PD therapy options that Vantive offers include continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD).

Homechoice Claria machine next to the patient's bedside
Man sleeping at home next to treatment machine
CAPD therapy (manual exchange)

CAPD has several benefits in comparison to other types of dialysis. Waste products and excess fluid can be removed manually during the treatment process, which may reduce stress on a patient's body. While doing CAPD, patients may be able to eat more of the foods they enjoy and take fewer medications than if they were doing haemodialysis (HD).12

APD therapy

APD automates the delivery of dialysis solution to the patient, along with removing the excess fluid and waste. This therapy may provide increased flexibility with a patient's diet and the number of medications a patient needs to take while on dialysis.12

Vantive’s comprehensive PD portfolio includes the Homechoice Claria APD system, enabled by the Sharesource connectivity platform.

Learn more about the Homechoice Claria APD system.

Benefits of remote patient management (RPM)

Remote patient management — in which patients’ clinical data is digitally collected and transmitted to their hospital or clinic for monitoring and analysis — has shown trends indicating fewer hospitalisations, reduced patient drop-out, increased time on therapy, improved access to care and lower utilisation of healthcare resources.13-18

*Image does not depict real patient data.

Learn about Sharesource connectivity platform remote patient management
Woman on laptop viewing Sharesource remote patient management
Learn about Sharesource connectivity platform remote patient management

Evidence supporting RPM19-22

RPM technology enhances the experience of APD. When APD is combined with RPM, the flexibility PD offers patients is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read more
Patient lifestyle

MyPD

Gain clinical benefits of remote patient management for all peritoneal dialysis patients – APD and CAPD.

Learn about MyPD

PD solutions

Tailor prescriptions to patients' unique needs, with minimal waste.

Vantive, Homechoice Claria and Sharesource are trademarks of Vantive Health LLC or its affiliates.

References

  1. Guest S. Handbook of Peritoneal Dialysis. CreateSpace Independent Publishing Platform; 2010:9.

  2. François K, Bargman JM. Evaluating the benefits of home-based peritoneal dialysis. Int J Nephrol Renovasc Dis. 2014;7:447-455.

  3. Lee SW, Lee NR, Son SK, et al. Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach. Sci Rep. 2019;9(1):5905.

  4. Zazzeroni L, Pasquinelli G, Nanni E, Cremonini V, Rubbi I. Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis. Kidney Blood Press Res. 2017;42(4): 717-727.

  5. Marshall MR. The benefit of early survival on PD versus HD—why this is (still) very important. Perit Dial Int. 2020;40(4):405-418.

  6. Bargman JM, et al. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158-2162.

  7. Almasri JM, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg. 2016;64(1):236-243.

  8. Joachim E, et al. Association of pre-transplant dialysis modality and post-transplant outcomes: a meta-analysis. Perit Dial Int. 2017;37(3):259-265.

  9. Marshall MR, et al. A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int. 2022;42(1):39-47.

  10. United States Renal Data System. 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States: End Stage Renal Disease: Chapter 5. Hospitalization. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

  11. Mendelssohn DC, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555-561

  12. National Kidney Foundation. Peritoneal dialysis. 2024. Accessed September 20, 2024. https://www.kidney.org/kidney-topics/peritoneal-dialysis.

  13. Firanek C, Knowles MA, Sloand JA. The impact of automated peritoneal dialysis (APD) with remote patient management (RPM): changing the nursing paradigm to proactive clinical management (SP508). Poster presented at: 54th ERA-EDTA Congress; June 3-6, 2017; Madrid, Spain.

  14. Firanek C, Salas M, Gellens M, Gatesman RD, Wiebenson D, Sloand J. Discrepancy between prescripted and actual APD prescription delivery: identification using cycler remote management technology (MP-557). Poster presented at: 54th ERA-EDTA Congress; June 3-6, 2017; Madrid, Spain.

  15. Makhija D, Alscher MD, Becker S, et al. Remote monitoring of automated peritoneal dialysis patients: assessing clinical and economic value. Telemed J E Health. 2018;24(4):315-323.

  16. Rivera AS, Sanabria M, Vesga J, Suarez AM, Bunch A. Comparison of hospitalization rate in automatized PD patients with and without remote management program in Colombia. J Am Soc Nephrol. 2018;29:595-596.

  17. Corzo L, Vesga J, Sanabria M, Rivera A. Clinical outcomes in remote patient monitoring in automated peritoneal dialysis: a Colombian experience. Nephrol Dial Transplant. 2020;35(suppl 3):gfaa142.P1151.

  18. Sanabria M, Vesga J, Lindholm B, Rivera A, Rutherford P. Time on therapy of automated peritoneal dialysis with and without remote patient monitoring: a cohort study. Int J Nephrol. 2022;2022:8646775.

  19. Firanek C, Salas M, Gellens M, Gatesman RD, Wiebenson D, Sloand J. Discrepancy between prescribed and actual APD prescription delivery: Identification using cycler remote management technology. Neph Dial Trans. 2017;32(suppl 3):iii633.

  20. Sanabria M, Buitrago G, Lindholm B, et al. Remote patient monitoring program in automated peritoneal dialysis: impact on hospitalizations. Perit Dial Int. 2019;39(5):472-478. 

  21. Wood E, McCarthy K, Roper M. Remote monitoring of peritoneal dialysis: evaluating the impact of the Claria Sharesource system. J Kidney Care. 2019;4(1):16-24.

  22. Firanek C, Knowles M, Sloand J. Impact of remote patient management in hospitals conducting APD: shifting the nursing care paradigm. Neph Dial Trans. 2017;32(suppl 3): iii300.